Cargando…

Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors

Although some individuals with HIV-2 develop severe immunodeficiency and AIDS-related complications, most may never progress to AIDS. Replication-competent HIV-2 isolated from asymptomatic long-term non-progressors (controllers) have lower replication rates than viruses from individuals who progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lungu, Cynthia, Overmars, Ronald J., Grundeken, Esmée, Boers, Patrick H. M., van der Ende, Marchina E., Mesplède, Thibault, Gruters, Rob A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675771/ https://www.ncbi.nlm.nih.gov/pubmed/38005913 http://dx.doi.org/10.3390/v15112236

Ejemplares similares

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients
por: Nicolas, Alexandre, et al.
Publicado: (2022)

HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report
por: van Kampen, Jeroen J.A., et al.
Publicado: (2022)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA
por: Lungu, Cynthia, et al.
Publicado: (2021)

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses
por: Pham, Hanh T., et al.
Publicado: (2016)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs
por: Buckheit, Robert W., et al.
Publicado: (2012)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals
por: Weber, Jan, et al.
Publicado: (2017)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
por: Yu, Hangxing, et al.
Publicado: (2013)

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
por: Meijerink, Hinta, et al.
Publicado: (2014)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

von Willebrand Factor is elevated in HIV patients with a history of thrombosis
por: van den Dries, Lennert W. J., et al.
Publicado: (2015)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2015)

Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA
por: Lungu, Cynthia, et al.
Publicado: (2020)

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

The latest evidence for possible HIV-1 curative strategies
por: Pham, Hanh Thi, et al.
Publicado: (2018)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
por: Mesplède, Thibault, et al.
Publicado: (2015)

Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors
por: Gaardbo, Julie Christine, et al.
Publicado: (2013)

Will LEDGIN molecules be able to play a role in a cure for HIV infection?
por: Mesplède, Thibault, et al.
Publicado: (2016)

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
por: Dam, Erik B, et al.
Publicado: (2009)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
por: Stefani, Chiara, et al.
Publicado: (2022)

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
por: Wainberg, Mark A, et al.
Publicado: (2015)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

A15 HIV-1 whole-genome NGS analysis to characterize virus evolution following dendritic cell immunotherapy and analytical treatment interruption
por: Lungu, C, et al.
Publicado: (2018)

Bridging HIV-1 Cellular Latency and Clinical Long-Term Non-Progressor: An Interactomic View
por: Yang, Jin, et al.
Publicado: (2013)

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
por: Hao, Yuxia, et al.
Publicado: (2015)

Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1
por: Lee, Sun Young, et al.
Publicado: (2019)

Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors
por: Prabhu, Varsha M., et al.
Publicado: (2019)

Non-polarized cytokine profile of a long-term non-progressor HIV infected patient
por: Pina, Ana Flávia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aatl0e8srnolks3kvq2ss6nnma